Curine Inhibits Macrophage Activation and Neutrophil Recruitment in a Mouse Model of Lipopolysaccharide-Induced Inflammation

Toxins (Basel). 2019 Dec 3;11(12):705. doi: 10.3390/toxins11120705.

Abstract

Curine is a bisbenzylisoquinoline alkaloid (BBA) with anti-allergic, analgesic, and anti-inflammatory properties. Previous studies have demonstrated that this alkaloid is orally active at non-toxic doses. However, the mechanisms underlying its anti-inflammatory effects remain to be elucidated. This work aimed to investigate the effects of curine on macrophage activation and neutrophil recruitment. Using a murine model of lipopolysaccharide (LPS)-induced pleurisy, we demonstrated that curine significantly inhibited the recruitment of neutrophils in association with the inhibition of cytokines tumor necrosis factor (TNF-α), interleukin (IL)-1β, IL-6, monocyte chemotactic protein (CCL2/MCP-1) as well as leukotriene B4 in the pleural lavage of mice. Curine treatment reduced cytokine levels and the expression of iNOS in in vitro cultures of macrophages stimulated with LPS. Treatment with a calcium channel blocker resulted in comparable inhibition of TNF-α and IL-1β production, as well as iNOS expression by macrophages, suggesting that the anti-inflammatory effects of curine may be related to the inhibition of calcium-dependent mechanisms involved in macrophage activation. In conclusion, curine presented anti-inflammatory effects that are associated with inhibition of macrophage activation and neutrophil recruitment by inhibiting the production of inflammatory cytokines, LTB4 and nitric oxide (NO), and possibly by negatively modulating Ca2+ influx.

Keywords: Curine; alkaloid; lipopolysaccharide; macrophage; neutrophil.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Calcium / metabolism
  • Cytokines / immunology
  • Disease Models, Animal
  • Inflammation / chemically induced
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Isoquinolines / pharmacology
  • Isoquinolines / therapeutic use*
  • Lipopolysaccharides
  • Macrophage Activation / drug effects*
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Male
  • Mice, Inbred C57BL
  • Neutrophil Infiltration / drug effects*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • Isoquinolines
  • Lipopolysaccharides
  • Nitric Oxide
  • curine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Calcium